Intercept Pharmaceuticals (NASDAQ:ICPT) reported its Q2 earnings results on Wednesday, August 3, 2022 at 07:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Intercept Pharmaceuticals missed estimated earnings by 525.0%, reporting an EPS of $-0.25 versus an estimate of $-0.04.
Revenue was down $24.82 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.32 which was followed by a 1.63% drop in the share price the next day.
Here’s a look at Intercept Pharmaceuticals’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.90 | -1.10 | -1.09 | -1.21 |
| EPS Actual | -0.58 | -1.23 | -0.63 | -0.33 |
| Revenue Estimate | 90.49M | 92.38M | 83.02M | 82.95M |
| Revenue Actual | 88.58M | 92.40M | 92.83M | 96.58M |
To track all earnings releases for Intercept Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
